Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P367: The availability of infliximab trough levels in IBD patients on maintenance therapy deeply impacts therapeutic decision-makingECCO '17 Barcelona
Year: 2017
Authors:

Lobaton T.*1, Cañete F.1, Teniente A.2, Cabre E.1,3, Mañosa M.1, Martínez E.2, Domènech E.1,3

1University Hospital Germans Trias i Pujol, Gastroenterology, Badalona (Barcelona), Spain 2University Hospital Germans Trias i Pujol, Immunology, Badalona (Barcelona), Spain 3CIBER, Badalona (Barcelona), Spain

P368: Treatment of inflammatory bowel disease in the elderlyECCO '17 Barcelona
Year: 2017
Authors:

Roque Ramos L.*1, Barosa R.1, Mocanu I.2, Patita M.1, Nunes G.1, Vieira A.I.1

1Hospital Garcia de Orta, Gastroenterology, Almada, Portugal 2Hospital Espirito Santo, Department of Gastroenterology, Έvora, Portugal

P369: Safety and lymphocyte-lowering properties of etrasimod (APD334), an oral, potent, next-generation, selective S1P receptor modulator, after dose escalation in healthy volunteersECCO '17 Barcelona
Year: 2017
Authors:

Peyrin-Biroulet L.1, Christopher R.2, Trokan L.2, Lassen C.2, Adams J.2, Kühbacher T.*3

1Nancy University Hospital and Lorraine University, Department of Gastroenterology, Nancy, France 2Arena Pharmaceuticals, Inc., San Diego, United States 3Asklepios Westklinikum Hamburg and Christian Albrechts University, Department of Internal Medicine/Gastroenterology, Kiel, Germany

P370: A randomised controlled trial of acceptance and commitment therapy for the treatment of stress in inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Mulcahy H.*1, Wynne B.2, McHugh L.2, Rowan C.1, Byrne K.1, Keegan D.1, Hartery K.1, Dooley B.2

1St Vincent's University Hospital, Centre for Colorectal Disease, Dublin, Ireland 2University College Dublin, School of Psychology, Dublin, Ireland

P371: Healthcare maintenance in inflammatory bowel disease patients: need for a top down approachECCO '17 Barcelona
Year: 2017
Authors:

Hazel K., Forry M., Patchett S., O'Toole A.

Beaumont Hospital, Department of Gastroenterology, Dublin, Ireland

P372: The long term course of patients undergoing ileal pouch-anal anastomosis for ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

Macaluso F.S.*1, Rossi F.2, Orlando A.1, Sapienza C.1, Sinagra E.2, Maisano S.1, Angelo C.1, Renna S.1, Linea C.3, Montalbano L.M.3, Giunta M.3, Solina G.4, Marchesa P.5, Ventimiglia M.1, Cottone M.1

1Division of Internal Medicine, “Villa Sofia-Cervello” Hospital, Palermo, Italy 2Gastroenterology and Endoscopy Unit, Fondazione Istituto San Raffaele Giglio, Cefalù, Italy 3Gastroenterology and Endoscopy Unit, “Villa Sofia-Cervello” Hospital, Palermo, Italy 4Unit of Surgery, “Villa Sofia-Cervello” Hospital, Palermo, Italy 5Unit of Surgery, Fondazione Istituto San Raffaele Giglio, Cefalù, Italy

P373: Real-file prospective experience with adalimumab in inducing remission in ulcerative colitis in Italian primary inflammatory bowel diseases centresECCO '17 Barcelona
Year: 2017
Authors:

Tursi A.*1, Allegretta L.2, Della Valle N.3, Elisei W.4, Forti G.5, Faggiani R.6, Lorenzetti R.7, Mocci G.8, Penna A.9, Pranzo G.10, Paiano P.11, Ricciardelli C.11, Gallina S.6, Picchio M.12

1Azienda Sanitaria Locale BAT, Servizio di Gastroenterologia Territoriale, Andria, Italy 2“Santa Caterina Novella” Hospital, Division of Gastroenterology, Galatina (LE), Italy 3A.O. “Ospedali Riuniti”, Division of Gastroenterology, Foggia, Italy 4ASL RMH, Division of Gastroenterology, Albano Laziale, Italy 5“S. Maria Goretti” Hospital, Digestive Endoscopy Unit, Latina, Italy 6“Belcolle” Hospital, Division of Gastroenterology, Viterbo, Italy 7PTP “Nuovo Regina Margherita”, Division of Gastroenterology, Rome, Italy 8“Brotzu” Hospital, Division of Gastroenterology, Cagliari, Italy 9“S. Paolo” Hospital, Division of Gastroenterology, Bari, Italy 10“Valle D'Itria” Hospital, Ambulatory for IBD Treatment, Martina Franca (TA), Italy 11“Veris Delli Ponti” Hospital, Division of Gastroenterology, Scorrano (LE), Italy 12“P. Colombo” Hospital, ASL RMH, Division of Surgery, Velletri, Italy

P374: Home or hospital-based analysis of stool calprotectin: assessing two methods for monitoring inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Heida A.*1, Knol M.1, Muller Kobold A.2, Dijkstra G.3, van Rheenen P.1

1University Medical Center Groningen, Pediatric Gastroenterology, Groningen, Netherlands 2University Medical Center Groningen, Laboratory Medicine, Groningen, Netherlands 3University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, Netherlands

P375: Intraoperative endoscopy is safe and helps to determine the resection extent in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Podmanicky D.*1, Stefanov V.1, Harustiakova D.2, Kovacs J.3, Zelinkova Z.3

1St Michael's Hospital, Department of Surgery, Bratislava, Slovakia 2St Michael's Hospital, Department of Anesthesiology and Intensive Care, Bratislava, Slovakia 3St Michael's Hospital, Department of Gastroenterology, Bratislava, Slovakia

P376: Assessment of nutritional status and food related experience of adult inflammatory bowel disease inpatientsECCO '17 Barcelona
Year: 2017
Authors:

Keetarut K.*1, Bloom S.2, Qu X.3, Grimble G.3

1University college london hospital, Nutrition and dietetics, London, United Kingdom 2University College Hospital, Department of Gastroenterology, London, United Kingdom 3University College London, Department of Gastroenterology and Nutrition, London, United Kingdom

P377: Evaluation of the pharmacokinetic profiles of SB5 and reference adalimumabECCO '17 Barcelona
Year: 2017
Authors:

Shin D.1, Kang J.W.2, Park S.2, Cheong S.Y.1, Hong E.*1

1Samsung Bioepis Co., Ltd, Medical Team, Incheon, South Korea 2Samsung Bioepis Co., Ltd, Quality Evaluation Team, Incheon, South Korea

P378: Renal AA amyloidosis associated with Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Bibani N., Gharbi O., Trad D., Sabbah M., Ouakaa A., Gargouri D., Elloumi H., Kharrat J.

Gastroenterology, Hospital of Habib Thameur, Tunis, Tunisia

P379: Is febuxostat the solution for patients who develop side effects to low dose azathioprine and allopurinol co-therapy?ECCO '17 Barcelona
Year: 2017
Authors:

Johnson H., Wade K., Hovell C., Weaver S., McLaughlin S.

Royal Bournemouth Hospital, Department of Gastroenterology, Bournemouth, United Kingdom

P380: Assessment of the awareness and education of vaccination in our IBD cohort: an observational studyECCO '17 Barcelona
Year: 2017
Authors:

Maheshwari P., Palaniappan S.K., Moran C., Forry M., Parihar V., Hall B., Reilly M., O'Toole A.

Beaumont Hospital Dublin, Gastroenterology, Dublin, Ireland

P381: Adalimumab efficacy and safety by disease duration: analysis of pooled studies of Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Panaccione R.*1, Rutgeerts P.2, Sandborn W.3, Schreiber S.4, Colombel J.-F.5, Berg S.6, Maa J.-F.7, Petersson J.7, Robinson A.M.7

1University of Calgary, Department of Medicine, Calgary, Canada 2University of Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium 3University of California San Diego, Division of Gastroenterology, La Jolla, United States 4University Hospital Schleswig-Holstein, Department of Internal Medicine I, Kiel, Germany 5Icahn School of Medicine at Mount Sinai, New York, United States 6AbbVie AB, Solna, Sweden 7AbbVie Inc., North Chicago, United States

P382: A panel of serum markers for early detection of endoscopic healing with infliximab in patients with ulcerative colitisECCO '17 Barcelona
Year: 2017
Authors:

de Bruyn M.*1,2, Ringold R.3, Ferrante M.2,4, Van Assche G.2,4, Opdenakker G.1, Dukler A.3, Vermeire S.2,4

1Rega Institute for Medical Research, KU Leuven, Department of Microbiology and Immunology, Laboratory of Immunobiology, Leuven, Belgium 2KU Leuven, Department of Clinical and Experimental Medicine, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium 3Kepler Diagnostics, Inc., Simi Valley, CA, United States 4University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium

P383: Increasing treatment time on REMICADE® (infliximab) predicts subsequent long-term retention in stable infliximab inflammatory bowel disease patients in CanadaECCO '17 Barcelona
Year: 2017
Authors:

Marshall J.K.*1,2, Marrache A.M.3, Ewara E.4

1McMaster University Medical Center, Department of Gastroenterology, Hamilton, Canada 2Farncombe Family Digestive Health Research Institute, Hamilton, Canada 3Janssen Inc., Medical Affairs, Toronto, Canada 4Janssen Inc., Government Affairs and Market Access, Toronto, Canada

P384: Long-term outcome and endoscopic healing rates following long modified side-to-side strictureplastiesECCO '17 Barcelona
Year: 2017
Authors:

Van Stappen J.*1, De Buck van Overstraeten A.2, Ferrante M.1, Vanbeckevoort D.3, Van Assche G.1, D'Hoore A.2, Vermeire S.1

1University Hospitals Leuven, Gastroenterology, Leuven, Belgium 2University Hospitals Leuven, Abdominal surgery, Leuven, Belgium 3University Hospitals Leuven, Radiology, Leuven, Belgium

P385: Assessment of long-term outcomes of patients with ulcerative colitis and mucosal healing under different therapies: Is all mucosal healing the same?ECCO '17 Barcelona
Year: 2017
Authors:

Raimundo Fernandes S.*1, Correia L.1, Baldaia C.2, Moura Santos P.2, Rita Gonçalves A.2, Valente A.2, Velosa J.1

1Hospital de Santa Maria, Serviço de Gastrenterologia e Hepatologia, Lisboa, Portugal 2Centro Hospitalar Lisboa Norte, Gastrenterology, Lisbon, Portugal

P386: A target 6-thioguanine nucleotide ≥125 is associated with a higher rate and longer durability of response in infliximab–thiopurine combination therapy: a retrospective study in Crohn's disease patientsECCO '17 Barcelona
Year: 2017
Authors:

Luber R.*1,2, Kariyawasam V.3, Dawson L.1, Munari S.1, Gibson P.1,2, Sparrow M.1,2, Ward M.1,2

1The Alfred Hospital, Department of Gastroenterology, Melbourne, Australia 2Monash University, Melbourne, Australia 3University of Western Sydney, Department of Gastroenterology, Sydney, Australia